Prestige Consumer Healthcare
PBH
#4677
Rank
A$3.30 B
Marketcap
A$69.82
Share price
0.39%
Change (1 day)
-41.62%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$6.20

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.80. In 2024 the company made an earnings per share (EPS) of A$6.19 an increase over its 2023 EPS that were of A-$2.32.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$6.200.13%
2024A$6.19-367.08%
2023A-$2.32-138.33%
2022A$6.0511.7%
2021A$5.4213.6%
2020A$4.77-651.67%
2019A-$0.86-148.78%
2018A$1.77-83.29%
2017A$10.60437.23%
2016A$1.97-34.13%
2015A$3.0052.94%
2014A$1.96-8.11%
2013A$2.13
2011A$1.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.58 116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.07 73.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.11 74.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.89-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.20-10.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.90 53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$3.33-42.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.60-3.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.66-834.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.76-69.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel